Arnuity ellipta and Ergocalciferol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arnuity ellipta (fluticasone furoate) and Ergocalciferol (ergocalciferol). Common drug interactions include anaemia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Arnuity ellipta and Ergocalciferol. It is created by eHealthMe based on reports of 76 people who take the same drugs from the FDA, and is updated regularly.

What is Arnuity ellipta?

Arnuity ellipta has active ingredients of fluticasone furoate. eHealthMe is studying from 3,482 Arnuity ellipta users. Check the latest studies of Arnuity ellipta.

What is Ergocalciferol?

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.



On Jul, 23, 2026

76 people who take Arnuity ellipta and Ergocalciferol together, and have interactions are studied.

Arnuity ellipta and Ergocalciferol drug interactions.

What are the common drug interactions of Arnuity Ellipta and Ergocalciferol, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Colitis (inflammation of colon)
  3. Colitis ulcerative (inflammation of colon with ulcer)
  4. Constipation
  5. Wheezing (a high-pitched whistling sound made while you breath)
  6. Asthma
  7. Rhinorrhoea (watery mucus discharge from the nose)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  10. Chest discomfort

male:

  1. Anxiety
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Joint swelling
  4. Nasal dryness (dry nose)
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Oedema peripheral (superficial swelling)
  7. Oxygen saturation decreased
  8. Pneumonia
  9. Proteinuria (presence of protein in the urine)
  10. Chronic kidney disease

What are the common drug interactions of Arnuity Ellipta and Ergocalciferol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Angioedema (rapid swelling of the dermis)
  2. Asthma
  3. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  4. Conjunctivitis allergic (inflammation of the conjunctiva due to allergy)
  5. Ear pruritus (pruritus or itching is ""the unpleasant skin sensation that frequently provokes scratching"" in ear)
  6. Paranasal sinus discomfort
  7. Rhinitis allergic (inflammation of the nasal airways due to allergy)
  8. Rhinorrhoea (watery mucus discharge from the nose)
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Wheezing (a high-pitched whistling sound made while you breath)

30-39:

  1. Angioedema (rapid swelling of the dermis)
  2. Asthma
  3. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  4. Ear pruritus (pruritus or itching is ""the unpleasant skin sensation that frequently provokes scratching"" in ear)
  5. Paranasal sinus discomfort
  6. Urticaria (rash of round, red welts on the skin that itch intensely)
  7. Wheezing (a high-pitched whistling sound made while you breath)
  8. Conjunctivitis allergic (inflammation of the conjunctiva due to allergy)
  9. Rhinitis allergic (inflammation of the nasal airways due to allergy)
  10. Rhinorrhoea (watery mucus discharge from the nose)

40-49:

n/a

50-59:

  1. Pruritus (severe itching of the skin)
  2. Rhinorrhoea (watery mucus discharge from the nose)
  3. Seasonal allergy (allergic condition due to certain season)
  4. Skin infection
  5. Speech disorder
  6. Stress
  7. Swelling
  8. Weight decreased
  9. Wheezing (a high-pitched whistling sound made while you breath)
  10. Arthralgia (joint pain)

60+:

  1. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Chest discomfort
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Cough
  6. Depression
  7. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  8. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  9. Obstruction
  10. Productive cough

What are the existing conditions these people have? *

  1. Asthma: 61 people, 80.26%
  2. Sinus Disorder (disease of sinus): 50 people, 65.79%
  3. Hypereosinophilic Syndrome (group of disorders marked by the sustained overproduction of eosinophiles): 7 people, 9.21%

* Approximation only. Some reports may have incomplete information.

Do you take Arnuity ellipta and Ergocalciferol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Arnuity ellipta and Ergocalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Arnuity ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ergocalciferol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arnuity ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ergocalciferol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fluticasone furoate and ergocalciferol (the active ingredients of Arnuity ellipta and Ergocalciferol, respectively), and Arnuity ellipta and Ergocalciferol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: